TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Official Start of the Demonstrator US Tour for Its FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the beginning of the Mullen FIVE Strikingly Different EV Crossover Tour, which will commence on Oct. 27 in Pasadena, California. Due to overwhelming interest, the tour has been expanded to add new dates of Nov. 1 and 2 at Angel Stadium in Anaheim, California. “When we announced the Pasadena location, we received an overwhelmingly positive response and were completely booked out in a matter of hours. So, we decided to add an additional LA area stop to ensure more people have the opportunity to experience the FIVE,” said David Michery, CEO and chairman of Mullen Automotive. “It’s been a remarkable journey for us to get to this point of officially starting the Mullen FIVE demonstrator U.S. tour. We’re beyond grateful for the incredible support we’ve received so far.”

To view the full news release, visit https://ibn.fm/eXbcR

About Mullen Automotive Inc.

Mullen is a Southern California-based automotive company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the United States. With an end-to-end ecosystem that supports owners from test driving to financing and servicing through a unique hybrid dealership model, customers are supported through every aspect of EV ownership. The Mullen FIVE, the company’s first electric crossover, is slated for delivery in 2024 and features an award-winning design and its patented PERSONA technology that utilizes facial recognition to personalize the driving experience for every individual. To learn more about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers,…

6 hours ago

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Reaches Settlement Agreement with GEM Over Mishawaka Assets

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement…

1 day ago

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences…

1 day ago

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which…

5 days ago

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Record Revenue, Gross Profit and Cash Balance along with Quantum Supremacy Breakthrough in Q1

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted…

5 days ago

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Files C$200 Million Shelf Prospectus for Flexible Future Offerings

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) has filed a final…

5 days ago